Carson Wealth (CWM LLC)
FATE icon

Carson Wealth (CWM LLC)’s Fate Therapeutics FATE Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$168K Buy
139,796
+88,007
+170% +$107K ﹤0.01% 2874
2025
Q4 		$51K Sell
51,789
-14,304
-22% -$17.2K ﹤0.01% 3584
2025
Q3 		$83K Buy
66,093
+16,655
+34% +$18K ﹤0.01% 3128
2025
Q2 		$55K Buy
49,438
+8,003
+19% +$9.3K ﹤0.01% 3201
2025
Q1 		$33K Buy
41,435
+37,290
+900% +$45.7K ﹤0.01% 3312
2024
Q4 		$7K Buy
4,145
+3,277
+378% +$8.26K ﹤0.01% 4042
2024
Q3 		$3K Buy
868
+238
+38% +$926 ﹤0.01% 4271
2024
Q2 		$2K Buy
630
+80
+15% +$350 ﹤0.01% 4199
2024
Q1 		$4K Buy
550
+6
+1% +$37 ﹤0.01% 3754
2023
Q4 		$2K Sell
544
-2,310
-81% -$5.45K ﹤0.01% 3800
2023
Q3 		$6K Buy
2,854
+1,156
+68% +$3.83K ﹤0.01% 3360
2023
Q2 		$8K Buy
1,698
+774
+84% +$4.27K ﹤0.01% 3196
2023
Q1 		$5K Sell
924
-1,055
-53% -$6.37K ﹤0.01% 3281
2022
Q4 		$20K Buy
1,979
+1,071
+118% +$20.1K ﹤0.01% 2361
2022
Q3 		$20K Buy
908
+54
+6% +$1.56K ﹤0.01% 2214
2022
Q2 		$21K Buy
854
+838
+5,238% +$23.1K ﹤0.01% 2074
2022
Q1 		$1K Buy
16
+12
+300% +$465 ﹤0.01% 3338
2021
Q4 		$0 Buy
+4
New +$227 ﹤0.01% 3536

Other funds holding FATE

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Carson Wealth (CWM LLC)'s FATE Position: Q1 2026 in Review

Carson Wealth (CWM LLC) increased its Fate Therapeutics (FATE) stake by 170% in Q1 2026, buying an estimated $107K and bringing the position to 139,796 shares worth $168K. The position accounts for ﹤0.01% of the portfolio, ranked #2874.

Carson Wealth (CWM LLC) first reported a position in FATE in Q4 2021 and has held it in 18 quarters since. 158 funds tracked by Wall St. Rank hold FATE as of Q1 2026.

  • Carson Wealth (CWM LLC) held 139,796 shares of Fate Therapeutics worth $168K as of Q1 2026.
  • Carson Wealth (CWM LLC) bought 88,007 Fate Therapeutics shares in Q1 2026, an estimated $107K.
  • Fate Therapeutics made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #2874 holding.
  • Carson Wealth (CWM LLC) first reported a position in Fate Therapeutics in Q4 2021 and has held it in 18 quarters since.
  • 158 funds tracked by Wall St. Rank held Fate Therapeutics as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.